CDC updates testing, management guidance amid co-circulating flu, COVID … Pennsylvania long-term care legislative package includes high school credit for congregate care work … NJ nurses seek union...
Clinical briefs for Wednesday, Nov. 1
Nov 01, 2023
FDA: These over-the-counter eye drops can cause infections … Most chronic coughers hack 450+ times a day … Biden demands plan for managing health AI tools … High brain metabolism can predict Alzheimer’s...
Also in the News for Tuesday, Oct. 31
Oct 31, 2023
Healthpeak Properties to merge with Physicians Realty Trust in $21 billion deal …FDA issues new warning on eyedrops … Accura to shutter Iowa facility over ‘financial sustainability’
Researchers found that getting COVID-19 and flu shots together — or just getting the high-dose or adjuvanted flu shot alone — can slightly raise the risk for strokes, according to government health...
Clinical briefs for Thursday, Oct. 26
Oct 26, 2023
FDA to assess AstraZeneca’s at-home nasal flu shot … Study: Older Black people more likely get low-value diagnostic tests compared to whites, but older whites get worse screening tests, treatments...
Clinical briefs for Tuesday, Oct. 3
Oct 03, 2023
WHO: Switch back to trivalent flu shots … Vascular cells needed to form long-term memories … Radiation could treat inoperable kidney tumors … “Expired” COVID-19 tests may still be OK, feds say...
Study questions fish oil claims, popularity
Aug 24, 2023
One in every five adults aged more than 60 years takes fish oil supplements, despite many warnings that they have no benefit for heart health. A new study sheds light on what the product labels say that...
Clinical briefs for Thursday, Aug. 17
Aug 17, 2023
COVID shots in the same arm may give better immunity … Mild cognitive impairment linked to weaker decision-making … Older women with Parkinson’s disease aren’t exercising enough … FDA approves...
FDA greenlights first home COVID test with traditional premarket review
Jun 07, 2023
The Cue COVID-19 Molecular Test is the first at-home COVID-19 test to be granted marketing authorization outside of emergency use authorities, representing a new era of consumer access to diagnostic tests,...
A first: FDA approves drug to treat agitation in Alzheimer’s dementia
May 12, 2023
For the first time, the FDA has approved a drug to treat agitation related to Alzheimer’s disease dementia. Patient advocates are hailing the news, but prescribing the drug, an antipsychotic, may put...